Trulieve Cannabis Corp.

TRLV Healthcare Drug Manufacturers Specialty & Generic

Trulieve Cannabis Corp.’s revenue for fiscal 2025 (year ended December 2025) was $1.2 billion, roughly unchanged from fiscal 2024.

Revenue
−20.1%
EPS
−2,391.1%
Free cash flow
+24.5%
Total debt
−37.0%

Quarter to September 2026, against a year earlier

11.10 0.20 +1.83%
Market cap
$2.1B
P/E
0.0×
Fwd P/E
−5.6×
Dividend yield
—
F-score
6/9
Altman Z
0.98
Beneish M
−2.99
Dividend safety
n/a

Trulieve Cannabis Corp. (TRLV) Operating cash flow

Alert me on Operating cash flow

Trulieve Cannabis Corp.'s operating cash flow for fiscal 2025 was $272.8M, unchanged from fiscal 2024. Over the twelve months to 30 September 2026 it was $242.5M. Over the past ten years it has ranged from $12.9M (fiscal 2021) to $272.8M (fiscal 2025) — the current reading is the highest in ten years. Operating cash flow has risen for 4 consecutive fiscal years. Trulieve Cannabis Corp. ranks 15th of 84 Drug Manufacturers Specialty & Generic companies by operating cash flow.

Operating cash flow, annual

Embed this chart

Annual newest first

Period Operating cash flow Change
FY2025 $272.8M 0.49%
FY2024 $271.5M 34.50%
FY2023 $201.8M 773.92%
FY2022 $23.1M 79.07%
FY2021 $12.9M (87.06%)
FY2020 $99.6M —

Quarterly newest first

Period Operating cash flow Change
Sep 2026 $74.4M 40.04%
Jun 2026 $53.1M (4.60%)
Mar 2026 $55.7M (5.93%)
Dec 2025 $59.2M (22.47%)
19 more quarters

Against its own ten years

Low $12.9M High $272.8M
Ten-year median $150.7M
Current reading's percentile 100

Operating cash flow against peers

What Operating cash flow is

Operating Cash Flow shows how much cash a company’s day-to-day business actually brings in, after paying suppliers, staff and taxes.

Reported line item

The full definition of Operating cash flow →

More on TRLV